Clinical Trials List
2021-05-20 - 2026-12-31
Phase III
Recruiting2
Terminated3
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 陳世彬 未分科
- 陳世彬 Division of Neurology
- Hung-Yu Liu Division of Neurology
- 陳韋達 Division of Neurology
- YEN-FENG WANG Division of Neurology
- 賴冠霖 Division of Neurology
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 楊皓雯 Division of Neurology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 楊浚銘 Division of Neurology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
670 participants
